You are currently on the new version of our website. Access the old version .

11 Results Found

  • Article
  • Open Access
3 Citations
2,557 Views
12 Pages

Gastric Myoelectric Activity and Body Composition in Women with Binge Eating Disorder and Bulimia Nervosa: A Preliminary Trial Study

  • Seham H. Alyami,
  • Adel Alhamdan,
  • Hanan M. Alebrahim,
  • Ahmad H. Almadani,
  • Ghadeer S. Aljuraiban and
  • Mahmoud M. A. Abulmeaty

8 July 2023

Women with eating disorders (EDs) often complain of abnormal gastric responses, which may impact their eating patterns and, consequently, their body composition. Binge eating disorder (BED) and bulimia nervosa (BN) have been shown to affect gastric m...

  • Article
  • Open Access
2 Citations
2,809 Views
13 Pages

Association of Gastric Myoelectric Activity with Dietary Intakes, Substrate Utilization, and Energy Expenditure in Adults with Obesity

  • Mahmoud M. A. Abulmeaty,
  • Ghadeer S. Aljuraiban,
  • Dara Aldisi,
  • Batool Albaran,
  • Zaid Aldossari,
  • Thamer Alsager,
  • Suhail Razak,
  • Yara Almuhtadi,
  • Eman El-Shorbagy and
  • Mohamed Berika
  • + 2 authors

28 September 2022

Obesity can modulate gastric myoelectric activity (GMA); however, the relationship of GMA with nutrient intakes and substrate utilization in adults with obesity is lacking. We examined the association of dietary intakes, energy expenditure, and subst...

  • Article
  • Open Access
10 Citations
3,321 Views
19 Pages

The Impact of Dextran Sodium Sulfate-Induced Gastrointestinal Injury on the Pharmacokinetic Parameters of Donepezil and Its Active Metabolite 6-O-desmethyldonepezil, and Gastric Myoelectric Activity in Experimental Pigs

  • Jan Bures,
  • Ilja Tacheci,
  • Jaroslav Kvetina,
  • Vera Radochova,
  • Lukas Prchal,
  • Darina Kohoutova,
  • Martin Valis,
  • Martin Novak,
  • Rafael Dolezal and
  • Marcela Kopacova
  • + 5 authors

Gastrointestinal side effects of donepezil, including dyspepsia, nausea, vomiting or diarrhea, occur in 20–30% of patients. The pathogenesis of these dysmotility associated disorders has not been fully clarified yet. Pharmacokinetic parameters of don...

  • Article
  • Open Access
1,037 Views
11 Pages

Effect of Feeding Route and Stroke Type on Gastric Myoelectric Activity in Stroke Survivor Patients: A Preliminary Study

  • Hissah F. Altimyat,
  • Alanoud Aladel,
  • Mahmoud Desoky,
  • Danyah Althuneyyan,
  • Norah Alshammari,
  • Laubna Alagel,
  • Laila Aljabri,
  • Rodan M. Desoky and
  • Mahmoud M. A. Abulmeaty

24 August 2025

Background/Objectives: Stroke survivors with dysphagia are usually fed with different feeding routes ranging from oral to percutaneous endoscopic gastrostomy (PEG). However, the impact of the feeding route on the gastric myoelectric activity (GMA) is...

  • Article
  • Open Access
2 Citations
2,292 Views
14 Pages

Gastric Myoelectric Activity and Body Composition Changes during Weight Loss via Sleeve Gastrectomy and Lifestyle Modification: Prospective Cohort Study

  • Mahmoud M. A. Abulmeaty,
  • Dara Aldisi,
  • Mohamed Al Zaben,
  • Ghadeer S. Aljuraiban,
  • Abdulaziz Alkhathaami,
  • Ali M. Almajwal,
  • Eman El Shorbagy,
  • Yara Almuhtadi,
  • Zaid Aldossari and
  • Thamer Alsager
  • + 2 authors

The capability of bariatric surgery (BS) and lifestyle intervention (LSI) in ameliorating obesity-associated altered gastric myoelectric activity (GMA) in relation to body composition is underinvestigated. This work studied GMA during weight loss via...

  • Article
  • Open Access
5 Citations
2,949 Views
13 Pages

Dextran Sodium Sulphate-Induced Gastrointestinal Injury Further Aggravates the Impact of Galantamine on the Gastric Myoelectric Activity in Experimental Pigs

  • Jan Bures,
  • Ilja Tacheci,
  • Jaroslav Kvetina,
  • Vera Radochova,
  • Darina Kohoutova,
  • Martin Valis,
  • Stanislav Rejchrt,
  • Veronika Knoblochova and
  • Jana Zdarova Karasova

Galantamine has been used as a treatment for Alzheimer disease. It has a unique, dual mode of action (inhibitor of acetylcholinesterase and allosteric modulator of nicotinic acetylcholine receptors). Nausea (in about 20%), vomiting (10%) and diarrhoe...

  • Article
  • Open Access
1,411 Views
15 Pages

Background: Upper gastrointestinal (GI) motility disorders, such as gastroparesis and functional dyspepsia (FD), contribute significantly to morbidity, especially in populations at risk for type 2 diabetes. However, the prevalence and clinical manife...

  • Review
  • Open Access
17 Citations
9,957 Views
16 Pages

20 February 2023

Gastric motility abnormalities are common in patients with disorders of gut-brain interaction, such as functional dyspepsia and gastroparesis. Accurate assessment of the gastric motility in these common disorders can help understand the underlying pa...

  • Article
  • Open Access
13 Citations
4,981 Views
14 Pages

Impaired Gastric Myoelectrical Reactivity in Children and Adolescents with Obesity Compared to Normal-Weight Controls

  • Katja Weimer,
  • Helene Sauer,
  • Bjoern Horing,
  • Francesco Valitutti,
  • Nazar Mazurak,
  • Stephan Zipfel,
  • Andreas Stengel,
  • Paul Enck and
  • Isabelle Mack

31 May 2018

Obesity often has its onset in childhood and can be accompanied by various comorbidities such as functional gastrointestinal disorders and altered gastric myoelectrical activity (GMA). This study investigates whether obesity in childhood and adolesce...

  • Article
  • Open Access
12 Citations
4,153 Views
15 Pages

Lessons Learned: Gastric Motility Assessment During Driving Simulation

  • Nenad B. Popović,
  • Nadica Miljković,
  • Kristina Stojmenova,
  • Grega Jakus,
  • Milana Prodanov and
  • Jaka Sodnik

19 July 2019

In the era of technological advances and innovations in transportation technologies, application of driving simulators for the investigation and assessment of the driving process provides a safe and suitable testing environment. Although driving simu...

  • Article
  • Open Access
3 Citations
2,556 Views
10 Pages

Development of a Gastrointestinal-Myoelectrical-Activity-Based Nomogram Model for Predicting the Risk of Mild Cognitive Impairment

  • Baichuan Li,
  • Shuming Ji,
  • Anjiao Peng,
  • Na Yang,
  • Xia Zhao,
  • Peimin Feng,
  • Yunwu Zhang and
  • Lei Chen

12 December 2022

Mild cognitive impairment (MCI) is the prodromal stage and an important risk factor of Alzheimer’s disease (AD). Interventions at the MCI stage are significant in reducing the occurrence of AD. However, there are still many obstacles to the scr...